Skip to content
Trial Eligibility
Menu

Effects of High Altitude on AMPK Activation

NCT02391519

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Pregnancy elicits adaptive changes in uteroplacental blood flow, which are altered at high altitude and may contribute to the observed 3-fold increase in intrauterine growth restriction (IUGR) and preeclampsia (PreE). The investigators propose to collect myometrial, cord blood, and placental tissue samples from women at high altitude (Summit County) and low altitude (Denver) in Colorado in order to determine if residence at altitude during pregnancy changes the vasoreactivity of myometrial arteries (MA).

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Pregnancy
  • IUGR
  • Preeclampsia

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 45 years
Sex
Female
Healthy volunteers
Accepted
Sponsor
University of Colorado, Denver
Last updated on ClinicalTrials.gov
February 13, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Colorado · 1

  • University of Colorado Denver Anschutz Medical Campus · Aurora, CO

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.